Hierarchy | Jotup

Anaergia Announces Escrow Closing of Second Tranche of the Strategic Investment

Retrieved on:

Friday, March 29, 2024

Other Energy, Environment, Utilities, Alternative Energy, Green Technology, Energy, Unit, Hierarchy, TSX, News, Inc.

The 34,000,000 units of the Company (“Units”) in respect of the second tranche will be released from escrow following Anaergia’s receipt of the gross proceeds expected forthwith.

Key Points:

The 34,000,000 units of the Company (“Units”) in respect of the second tranche will be released from escrow following Anaergia’s receipt of the gross proceeds expected forthwith.
Each Warrant entitles the holder to purchase one additional Subordinate Voting Share at an exercise price of C$0.80 for a period of three years following the closing of the first tranche of the Strategic Investment.
In connection with the closing of the second tranche of the Strategic Investment, Assaf Onn, a nominee of Marny, will be appointed to the Company’s board of directors to fill the vacancy to be created by the resignation of Douglas Fridrik Parkhill.
The third tranche of the Strategic Investment, with respect to 36,750,000 Units for gross proceeds of C$14.7 million, is expected to close by April 5, 2024, subject to a limited number of customary conditions.

Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements

Retrieved on:

Wednesday, March 13, 2024

Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Specialty, Hierarchy, Tax, Webcast, EDGAR, Bank statement, Cresco Labs, GAAP, Depreciation, Eastern Time Zone, Core, Total, Video game

Fourth quarter revenue of $188 million, excluding the impact from strategic divestitures aimed to drive profitability, down 2% year-over-year.

Key Points:

Fourth quarter revenue of $188 million, excluding the impact from strategic divestitures aimed to drive profitability, down 2% year-over-year.
Fourth quarter adjusted EBITDA1 nearly doubled year-over-year to $55 million, or 29% of revenue, a 1,400 bps improvement.
1 See “Non-GAAP Financial Measures” at the end of this press release for more information regarding the Company’s use of non-GAAP financial measures.
As of December 31, 2023, current assets were $278 million, including cash, cash equivalents and restricted cash of $109 million.

Nuvei enters into agreement to be taken private by Advent International, alongside existing Canadian shareholders Philip Fayer, Novacap and CDPQ at a price of US$34.00 per share

Retrieved on:

Monday, April 1, 2024

MONTREAL, April 1, 2024 /PRNewswire/ -- Nuvei Corporation ("Nuvei" or the "Company") (Nasdaq: NVEI) (TSX: NVEI), today announced that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") to be taken private by Advent International ("Advent"), one of the world's largest and most experienced global private equity investors, with the support of each of the Company's holders of multiple voting shares ("Multiple Voting Shares"), being Philip Fayer, certain investment funds managed by Novacap Management Inc. (collectively, "Novacap") and CDPQ, via an all-cash transaction which values Nuvei at an enterprise value of approximately US$6.3 billion. The Company will continue to be based in Montreal.

Key Points:

Nuvei will benefit from the significant resources, operational, and sector expertise, as well as the capacity for investment provided by Advent.
Philip Fayer will remain Nuvei's Chair and Chief Executive Officer and will lead the business in all aspects of its operations.
Fayer continued: "Our strategic initiatives have always focused on accelerating our customers revenue, driving innovation across our technology, and developing our people.
Bringing in a partner with such extensive experience in the payments sector will continue to support our development."

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

Retrieved on:

Thursday, March 7, 2024

MINNEAPOLIS, March 07, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced results from two new clinical data analyses from the AVOID-HF trial, which demonstrate the benefits of its Aquadex System in reducing heart failure readmissions at 30 days. Results from the analyses were presented in a late-breaking session at the Technology and Heart Failure Therapeutics (THT) conference in Boston.

Key Points:

Results from the analyses were presented in a late-breaking session at the Technology and Heart Failure Therapeutics (THT) conference in Boston.
Key findings demonstrating the benefits of AUF include:
Fewer heart failure events and heart failure hospitalizations: AUF patients had significantly fewer heart failure events within 30 days compared to ALD (90% vs 77.3% p=0.0138) and fewer heart failure hospitalizations for the AUF patients compared to the ALD patients (90.0% vs. 79.2% p=0.0321) within 30 days.
Key findings from the analysis include:
Top predictors for 90-day heart failure events: Using ML, the study identified the top 10 predictors for 90-day heart failure events.
Strong results for super-responders: 90% of patients categorized as super-responders to AUF therapy within this model did not experience any 90-day heart failure events.

Colliers International Group Inc. Completes US$300 Million Bought Deal Public Offering of Equity

Retrieved on:

Wednesday, February 28, 2024

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX and NASDAQ: CIGI) (“Colliers” or the “Company”) is pleased to report that it has closed its previously announced bought deal public offering of 2,479,500 subordinate voting shares (the “Subordinate Voting Shares”), at a price of US$121.00 per Subordinate Voting Share for gross proceeds of US$300.0 million (the “Offering”) with a syndicate of underwriters led by BMO Capital Markets and J.P. Morgan as joint bookrunners, and including Mizuho, National Bank Financial, RBC Capital Markets, Scotiabank, Merrill Lynch, BTIG, LLC, CIBC Capital Markets, Goldman Sachs, Raymond James, TD Securities, Wells Fargo and Stifel Nicolaus (the “Underwriters”).

Key Points:

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX and NASDAQ: CIGI) (“Colliers” or the “Company”) is pleased to report that it has closed its previously announced bought deal public offering of 2,479,500 subordinate voting shares (the “Subordinate Voting Shares”), at a price of US$121.00 per Subordinate Voting Share for gross proceeds of US$300.0 million (the “Offering”) with a syndicate of underwriters led by BMO Capital Markets and J.P. Morgan as joint bookrunners, and including Mizuho, National Bank Financial, RBC Capital Markets, Scotiabank, Merrill Lynch, BTIG, LLC, CIBC Capital Markets, Goldman Sachs, Raymond James, TD Securities, Wells Fargo and Stifel Nicolaus (the “Underwriters”).
Colliers has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any.
The net proceeds of the Offering will be used to repay balances outstanding on the Company’s credit facility and are intended to create additional capacity to fund potential future acquisition opportunities and growth initiatives, and for general corporate purposes.
No securities regulatory authority has either approved or disapproved of the contents of this news release.

Colliers International Group Inc. Announces US$300 Million Bought Deal Public Offering of Equity

Retrieved on:

Thursday, February 22, 2024

Acquisition, CIGI, Register, Suite, Telephone, BMO Capital Markets, TSX, Indian stock exchange, Colliers (company), EDGAR, Sale, ATTN:, Form, Collier, Broadridge Financial Solutions, Hierarchy, Offering, Security (finance)

Colliers has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any.

Key Points:

Colliers has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any.
The Offering is expected to close on or about February 28, 2024.
Subordinate Voting Shares may also be offered on a private placement basis in other international jurisdictions in reliance on applicable private placement exemptions.
Copies of the applicable offering documents, when available, can be obtained free of charge under the Company’s profile on SEDAR+ at www.sedarplus.com and EDGAR at www.sec.gov.

Onex First-Quarter Dividend Declared

Retrieved on:

Thursday, February 22, 2024

Private equity, TSX, Toronto Stock Exchange, Onex Corporation, ONEX, Hierarchy, Insurance

TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Onex Corporation (TSX: ONEX) today declared a first-quarter dividend of C$0.10 per Subordinate Voting Share payable on April 30, 2024 to shareholders of record on April 10, 2024.

Key Points:

TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Onex Corporation (TSX: ONEX) today declared a first-quarter dividend of C$0.10 per Subordinate Voting Share payable on April 30, 2024 to shareholders of record on April 10, 2024.
Onex is an investor and asset manager that invests capital on behalf of Onex shareholders and clients across the globe.
In total, Onex has US$49.7 billion in assets under management, of which US$8.1 billion is Onex’ own investing capital.
Onex is listed on the Toronto Stock Exchange under the symbol ONEX.

Curaleaf Reports Fourth Quarter and Full Year Ended 2023 Results

Retrieved on:

Wednesday, March 6, 2024

Acquisition, Purchasing, Net, TSX, Toronto Stock Exchange, Growth, Table, ID, GMP, Hierarchy, GAAP, Depreciation, Automation, Tax, Public expenditure, Cannabis, Video game

NEW YORK, March 6, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the fourth quarter ended December 31, 2023. All financial information is reported in accordance with U.S. generally accepted accounting principles (GAAP) and is provided in U.S. dollars unless otherwise indicated.

Key Points:

Fourth quarter 2023 adjusted EBITDA(1) of $83 million, representing 24% of revenue, a 490 basis point improvement year-over-year.
NEW YORK, March 6, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the fourth quarter ended December 31, 2023.
Matt Darin, Chief Executive Officer of Curaleaf, commented, "Our fourth quarter results are a solid reflection of the discipline and rigor we have put into evolving our business and the committed work of our team members.
Curaleaf reports its financial results in accordance with GAAP and uses a number of financial measures and ratios when assessing its results and measuring overall performance.

Thinkific Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on:

Monday, March 4, 2024

Gross margin decreased from 78% recorded for the fourth quarter last year to 75% due to an increasing mix of Thinkific Commerce.

Key Points:

Gross margin decreased from 78% recorded for the fourth quarter last year to 75% due to an increasing mix of Thinkific Commerce.
Net income for the fourth quarter of 2023 was $0.3 million, compared to a net loss of $3.7 million in the fourth quarter of 2022.
Total Paying Customers(2) grew 4% to 34.8 thousand in the fourth quarter of 2023 compared to the prior year.
GMV(2) in the fourth quarter was $115 million, up 9% compared to the fourth quarter of 2022.

Hierarchy Advertising takes center stage at Houston's 62nd American Advertising Awards with a total of 26 accolades

Retrieved on:

Tuesday, February 27, 2024

Conference, Advertising, Houston Grand Opera, American Advertising Federation, Lone Star College System, AAF, Motto, Hierarchy, Best in Show, Happiness

HOUSTON, Feb. 27, 2024 /PRNewswire/ -- Hierarchy Advertising had another golden night at the American Advertising Awards of Houston on February 15.

Key Points:

HOUSTON, Feb. 27, 2024 /PRNewswire/ -- Hierarchy Advertising had another golden night at the American Advertising Awards of Houston on February 15.
Hierarchy Advertising takes center stage at Houston's 62nd American Advertising Awards with a total of 26 accolades.
But as much as they are grateful for the accolades, Hierarchy knows this all means nothing without meeting clients' business goals first.
Because for Hierarchy, it's more than just blood-pumping creative; it's nurturing client relationships for lasting impacts.